Page 736 - Textbook of Pathology, 6th Edition
P. 736

720   5. Invasion. One of the important diagnostic features of  (WHO) histologic grading categorising prostate cancer into
            malignancy in prostate is the early and frequent   grade I (well-differentiated), grade II (moderately
            occurrence of invasion of intra-prostatic perineural spaces.  differentiated) and grade III (poorly differentiated) has
            Lymphatic and vascular invasion may be present but are  largely been replaced with Gleason’s microscopic grading
            difficult to detect.                               system which is based on two features:
                                                               i) Degree of glandular differentiation.
           SPREAD. The tumour spreads within the gland by direct  ii) Growth pattern of the tumour in relation to the stroma.
           extension, and to distant sites by metastases.         These features are assessed by low-power examination
                                                               of the prostatic tissue.  For clinical staging of prostate cancer,
           Direct spread. Direct extension of the tumour occurs into  TNM system is considered international standard.
           the prostatic capsule and beyond. In late stage, the tumour
           may extend into the bladder neck, seminal vesicles, trigone  The diagnosis of prostatic carcinoma is made by
           and ureteral openings.                              cytologic, biochemical, radiologic, ultrasonographic and
                                                               pathologic methods. However, definite diagnosis is
           Metastases. Distant spread occurs by both lymphatic and  established by histopathologic examination of transrectal
           haematogenous routes. The rich lymphatic network    ultrasound (TRUS)- guided core needle biopsy.
           surrounding the prostate is the main mode of spread to the  Two serum  tumour markers employed commonly for
           sacral, iliac and para-aortic lymph nodes. The earliest  diagnosis and monitoring the prognosis of prostatic
           metastasis occur to the obturator lymph node. Haemato-  carcinoma are as under:
           genous spread leads most often to characteristic osteoblastic
           osseous metastases, especially to pelvis, and lumbar spine;  Prostatic acid phosphatase (PAP) is secreted by prostatic
           other sites of metastases are lungs, kidneys, breast and brain.  epithelium. Elevation of serum level of PAP is found in cases
           The route of blood-borne metastases may be retrograde  of prostatic cancer which have extended beyond the capsule
           spread by prostatic venous plexus or via systemic circulation.  or have metastasised. PAP can also be demonstrated in the
                                                               normal prostatic tissues.
           CLINICAL FEATURES. By the time symptoms appear, the    Prostate-specific antigen (PSA) can be detected by
           carcinoma of prostate is usually palpable on rectal  immunohistochemical method in the malignant prostatic
           examination as a hard and nodular gland fixed to the  epithelium as well as estimated in the serum. A reading
           surrounding tissues. In such symptomatic cases, clinical  between 4 and 10 (normal 0-4 ng/ml) is highly suspicious
           features are: urinary obstruction with dysuria, frequency,  (10% risk) but value above 10 is diagnostic of prostatic carci-
     SECTION III
           retention of urine, haematuria, and in 10% of cases pain in  noma. PSA assay is useful in deciding whether the metastasis
           the back due to skeletal metastases.                originated from the prostate or not. PSA assay is also helpful
              Clinical staging of carcinoma prostate takes into account  in distinguishing high-grade prostatic cancer from urothelial
           the following:                                      carcinoma, colonic carcinoma, lymphoma and prostatitis.
              The tumour found incidentally or a clinically unsuspected  PSA level is generally higher in low-grade tumours than in
           cancer in prostate removed for benign disorder (Stage A).  high-grade tumours.
                                                                  Treatment of prostatic carcinoma consists of surgery,
              The tumour palpable by rectal digital examination but  radiotherapy and hormonal therapy. The hormonal depen-
           confined to the prostate (Stage B).                 dence of prostate cancer consists of depriving the tumour
              The tumour has extended locally beyond the prostate into  cells of growth-promoting influence of testosterone. This can
           the surrounding tissues (Stage C).                  be achieved by bilateral orchiectomy followed by
     Systemic Pathology
              The tumour is associated with distant metastases  administration of oestrogen. Surgical approaches for prostate
           (Stage D).                                          cancer include transurethral resection (TUR), radical
              Clinical staging has good correlation with histologic  prostatectomy and transurethral US-guided laser-induced
           grading and, thus, has a prognostic significance. Mostofi’s  prostatectomy (TULIP).

                                                                                                              ❑
   731   732   733   734   735   736   737   738   739   740   741